CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 74% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Close

Trade BioNTech BNTX

Sell
 Buy

BioNTech live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2025 Apr 13, 11:52

BioNTech SE (NASDAQ:BNTX) Shares Sold by Quinn Opportunity Partners LLC

BioNTech SE
Webhose 2025 Apr 13, 10:27

Scotia Capital Inc. Acquires 30,143 Shares of BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 Apr 11, 00:00

Sen. Johnson demands COVID vaccine makers hand over all documents, communications, as evidence against their products reaches a climax - NaturalNews.com

BioNTech SE
Webhose 2025 Apr 09, 08:30

Franklin Resources Inc. Buys 133,402 Shares of BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 Apr 06, 09:07

Cinctive Capital Management LP Buys Shares of 14,760 BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 Apr 02, 19:37

Is BioNTech SE (BNTX) the Best German Stock to Buy According to Hedge Funds?

BioNTech SE
Webhose 2025 Apr 02, 12:01

BioNTech (NASDAQ:BNTX) Price Target Cut to $145.00 by Analysts at HC Wainwright

BioNTech SE
Webhose 2025 Apr 02, 11:07

Groupama Asset Managment Buys 19,994 Shares of BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 Apr 02, 06:30

BioNTech SE (NASDAQ:BNTX) Receives Consensus Rating of "Moderate Buy" from Brokerages

BioNTech SE
Webhose 2025 Apr 01, 17:17

BioNTech (NASDAQ:BNTX) Shares Gap Down - Time to Sell?

BioNTech SE
Webhose 2025 Mar 29, 15:50

Analysts' Top Healthcare Picks: Ascentage Pharma Group International Unsponsored ADR (AAPG), BioNTech SE (BNTX) | Markets Insider

BioNTech SE
Webhose 2025 Mar 28, 10:26

Mitsubishi UFJ Trust & Banking Corp Has $21.37 Million Position in BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 Mar 28, 10:17

CureVac (CVAC) Rises 10% After Key Patent Victory; Other Movers

BioNTech SE
Webhose 2025 Mar 28, 01:32

European Patent Office declares CureVac mRNA patent valid

BioNTech SE
Webhose 2025 Mar 27, 22:26

CureVac (CVAC) Surges as European Court Validates Key Patent

BioNTech SE
Webhose 2025 Mar 27, 20:47

CORRECT: CureVac Says Patent Validated in Dispute With BioNTech

BioNTech SE
Webhose 2025 Mar 25, 21:40

Is BioNTech SE (BNTX) a Promising Biotech Stock According to Wall Street Analysts

BioNTech SE
Webhose 2025 Mar 22, 12:09

Autolus Therapeutics plc (NASDAQ:AUTL) Q4 2024 Earnings Call Transcript

BioNTech SE
Webhose 2025 Mar 21, 07:02

Autolus Therapeutics PLC (AUTL) Q4 2024 Earnings Call Highlights: Financial Growth Amid Rising Costs

BioNTech SE
Webhose 2025 Mar 18, 10:02

BioNTech SE (NASDAQ:BNTX) Shares Sold by Primecap Management Co. CA

BioNTech SE
Webhose 2025 Mar 17, 12:45

Morgan Stanley Keeps Their Buy Rating on BioNTech SE (BNTX) | Markets Insider

BioNTech SE
Webhose 2025 Mar 17, 09:12

Gallacher Capital Management LLC Sells 159 Shares of BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 Mar 16, 13:38

BioNTech SE (NASDAQ:BNTX) Analysts Just Slashed This Year's Estimates

BioNTech SE
Webhose 2025 Mar 16, 10:02

Vestcor Inc Has $1.13 Million Stake in BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 Mar 16, 07:08

BioNTech (NASDAQ:BNTX) Now Covered by Citigroup

BioNTech SE
Webhose 2025 Mar 15, 09:57

Lbp Am Sa Buys 5,085 Shares of BioNTech SE (NASDAQ:BNTX)

BioNTech SE

Latest news

Frances Wang 2024 Dec 29, 16:00

Stock market today: Most Asian stocks fell after US equities declined

Stocks
Frances Wang 2024 Dec 29, 16:00

MicroStrategy joins Nasdaq-100 index: MSTR stock performance analysis 2024

Cryptocurrencies Stocks
Dyogenes Diniz 2024 Dec 29, 16:00

Morning Note: Key Levels & Data Driving the Last Monday of 2024

Forex Morning Note USD
Closing 2024
Dyogenes Diniz 2024 Dec 26, 17:00

Week ahead: Closing 2024 and First Economic data from 2025

Forex Indices
Tesla soars
Dyogenes Diniz 2024 Dec 26, 17:00

Morning Note: Tesla Soars, AUDUSD Hits Key Support, Oil & SP500 Insights

Forex Oil S&P 500
Frances Wang 2024 Dec 26, 16:00

Nikkei 225 up 1.39%: Japanese Stocks Rise Following Yen's Continued Weakness

Stocks
Frances Wang 2024 Dec 25, 16:00

Asian stock market today: most Asian stocks rise amid thin holiday trading

Stocks
Frances Wang 2024 Dec 25, 16:00

Stock market today: Nasdaq, S&P 500, Dow surge ahead of Christmas break

Stocks

Info

Spread

0.7801

Spread (%)

0.8393 %

Leverage

1:5

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Friday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

23202729984

Shares Outstanding

240392992

Earnings Date (Next)

0000-00-00

Div Yield

2022-06-17

Ex-Dividend Date

2022-06-02

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-3.03

Learn more about this instrument

BioNTech BioNTech SE
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany. The company develops BNT111, which is in Phase 2 clinical trial for advance melanoma; BNT113, which is in Phase 2 clinical trial to treat head and neck squamous cell carcinoma; BNT116, which is in Phase I clinical trial for non-small cell lung cancer; BNT142, which is in phase 1/2 clinical trial for multiple solid tumors; BNT151, which is in phase 1/2 clinical trial for solid tumors; BNT152+BNT153, which is in phase 1 clinical trial for solid tumors; and BNT122/RO7198457, which is in Phase 2 clinical trial to treat adjuvant high-risk muscle-invasive urothelial carcinoma, colorectal cancer, pancreatic ductal adenocarcinoma, advance melanoma, as well as in phase 1a/1b clinical trial for advanced/metastatic solid tumors. It also develops BNT211, which is in phase 1 clinical trial to treat CLDN6+ solid tumors; BNT221, phase 1 clinical trial for the treatment of cancer; BNT311/GEN1046 (acasunlimab), which is in phase 3 clinical trial for solid tumors; BNT312/GEN1042, which is in phase 1/2 and 1 clinical trial to treat solid tumors; BNT314/GEN1059, which is in Phase 1/2 clinical trial for advanced or metastatic solid tumors; BNT315/GEN1055, which is in phase 1/2 clinical trial for advanced solid tumors; BNT317, which is in phase 1 clinical trial for advanced solid tumors; BNT327, which is in phase 1/2, 2, and 3 clinical trial to treat small cell lung cancer, advanced/metastatic tnbc, neuroendocrine neoplasm, malignant mesothelioma, EGFR-mutant non-squamous, hepatocellular carcinoma, and advanced solid tumors; and BNT316/ONC-392, which is in phase 1/2, 2, and 3 clinical trial to treat metastatic, non-small cell lung cancer, platinum-resistant ovarian cancer, metastatic castration resistant prostate cancer, and advanced or metastatic solid tumor. BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Germany.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments
Trustpilot
RequestMessages35TimelineExceptionsViews0RouteQueries0Models0MailsGateSession
SettingsRequest history38.1.18PHP Version14.74msRequest Duration2MBMemory UsageGET params
status
200 OK
full_url
https://web-qa.staging.markets.com/params
controller_action
App\Http\Controllers\TrackingParams@fetch
Theme
Open Button Position
Hide Empty Tabs
Autoshow
Reset to defaults
status
200 OK
full_url
https://web-qa.staging.markets.com/params
action_name
controller_action
App\Http\Controllers\TrackingParams@fetch
uri
GET params
controller
App\Http\Controllers\TrackingParams@fetch
file
app/Http/Controllers/TrackingParams.php:11-31
middleware
web
duration
14.94ms
peak_memory
6MB
response
application/json
request_format
html
request_query
[]
request_request
[]
request_headers
  0 of 0   
array:14 [▼
  "cookie" => array:1 [▶
    0 => "mktloc=eyJpdiI6ImxEemQ3aXJPQk5UM2tvYnoyVEtPaGc9PSIsInZhbHVlIjoiRmE3ZXpCbDdrTjFpMjNIUzZoQjk5WkVLeWdSWmlWZ3IxRHVuQ0kzN005N280WE1lTU9aY2hpWEo4MldSM0VKViIsIm1hYyI6IjM3ZmFjNmY4MmUyNjcyZDcyNTE5OWU1OTFlOTExOTJmMGVkZjQ4NmQxOTk1MTMwZDhiM2MyOWFjMzk0NWY4YjQiLCJ0YWciOiIifQ%3D%3D; mktv4_ip_override=en; firstURL=https://web-qa.staging.markets.com/en/instrument/prosusnv/; lastURL=https://web-qa.staging.markets.com/en/instrument/prosusnv/; intent_group=%252Fen%252Finstrument%252Fbiontech%252F; intent_instrument=biontech; XSRF-TOKEN=eyJpdiI6Ii9IWHpvaG95SWpiY0JUOStJZzBnc2c9PSIsInZhbHVlIjoiVjlPcEV2VTIrOTE4RU5IK3pxNU1zcjgvRzdqZ3B4Z2xrem9CZ0tBTmw4ZVRNNGVja05uZ0JsdDBJbm1DR0lvN3JWRzJBVzBuV2V6MmdwYlRPSkFhN29hbXU3dHJQejBWZ2FnbW5odzFweStYQll4Z1o3OWppYWk5TlFmbVZMOFciLCJtYWMiOiIyNGRiZDg3NWM1M2ZkNjg1MzczMWE5ZjAyOWZmYmQ5ZTA5ZWQ0MDRjODI4YmY0NjdjMmZhZjQ1MmE1ZGI3ZTk2IiwidGFnIjoiIn0%3D; laravel_session=eyJpdiI6Ik43Z1huVC9RRmlsU2JRTktsZHJma3c9PSIsInZhbHVlIjoiOEx2ejkydnRTb0hMam9KRTVoRnRFaXFEcXFCZlFtY1VWSkR3dWdvMEJ4M3VsZi8xcG5FTHNCRXZWdXROd1JKZVQ2WWI0bGlObk9wN3pSbTVreW80TkdXSVBReXlVd1QyNVM2VS9vY3JMeDdVbVBSbVJBQmFoMEZTNk1wTk0xcnEiLCJtYWMiOiI5ZGQxOWJlNGQ0YTEwYWRiYzdmYWY4YTVmZDcxOTNlNmVjNzU2MWIzMWVhNzQ5OTc1Mjc2MGZhZWZlOTgyMjk2IiwidGFnIjoiIn0%3D ◀mktloc=eyJpdiI6ImxEemQ3aXJPQk5UM2tvYnoyVEtPaGc9PSIsInZhbHVlIjoiRmE3ZXpCbDdrTjFpMjNIUzZoQjk5WkVLeWdSWmlWZ3IxRHVuQ0kzN005N280WE1lTU9aY2hpWEo4MldSM0VKViIsIm1hYyI6I ▶"
  ]
  "accept-encoding" => array:1 [▶
    0 => "gzip, deflate, br, zstd"
  ]
  "sec-fetch-dest" => array:1 [▶
    0 => "empty"
  ]
  "sec-fetch-mode" => array:1 [▶
    0 => "cors"
  ]
  "sec-fetch-site" => array:1 [▶
    0 => "same-origin"
  ]
  "accept" => array:1 [▶
    0 => "*/*"
  ]
  "sec-ch-ua-mobile" => array:1 [▶
    0 => "?0"
  ]
  "sec-ch-ua" => array:1 [▶
    0 => ""HeadlessChrome";v="129", "Not=A?Brand";v="8", "Chromium";v="129""
  ]
  "user-agent" => array:1 [▶
    0 => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)"
  ]
  "sec-ch-ua-platform" => array:1 [▶
    0 => ""Windows""
  ]
  "cache-control" => array:1 [▶
    0 => "no-cache"
  ]
  "pragma" => array:1 [▶
    0 => "no-cache"
  ]
  "connection" => array:1 [▶
    0 => "keep-alive"
  ]
  "host" => array:1 [▶
    0 => "web-qa.staging.markets.com"
  ]
]
request_cookies
  0 of 0   
array:8 [▼
  "mktloc" => "us,us"
  "mktv4_ip_override" => null
  "firstURL" => null
  "lastURL" => null
  "intent_group" => null
  "intent_instrument" => null
  "XSRF-TOKEN" => "6WSPwGZkuf3FrxzVzCOUciV7qfztvpar5A2JJ3de"
  "laravel_session" => "4lb0LevMOQkOeJrIn40zXeUZvRUL2CRETHeAzgRp"
]
response_headers
  0 of 0   
array:3 [▼
  "cache-control" => array:1 [▶
    0 => "no-cache, private"
  ]
  "date" => array:1 [▶
    0 => "Sun, 13 Apr 2025 15:23:15 GMT"
  ]
  "content-type" => array:1 [▶
    0 => "application/json"
  ]
]
session_attributes
  0 of 0   
array:4 [▼
  "_token" => "6WSPwGZkuf3FrxzVzCOUciV7qfztvpar5A2JJ3de"
  "PHPDEBUGBAR_STACK_DATA" => []
  "_previous" => array:1 [▶
    "url" => "https://web-qa.staging.markets.com/csrf"
  ]
  "_flash" => array:2 [▶
    "old" => []
    "new" => []
  ]
]
    • Booting (12.69ms)time
    • Application (2.05ms)time
    • Routing (474μs)
    • 1 x Booting (86.05%)
      12.69ms
      1 x Application (13.89%)
      2.05ms
      1 x Routing (3.21%)
      474μs
      0 templates were rendered
        uri
        GET params
        middleware
        web
        controller
        App\Http\Controllers\TrackingParams@fetch
        file
        app/Http/Controllers/TrackingParams.php:11-31
        0 statements were executed0μs
              _token
              6WSPwGZkuf3FrxzVzCOUciV7qfztvpar5A2JJ3de
              PHPDEBUGBAR_STACK_DATA
              []
              _previous
              array:1 [ "url" => "https://web-qa.staging.markets.com/csrf" ]
              _flash
              array:2 [ "old" => [] "new" => [] ]
              ClearShow all
              Date ↕MethodURLData
              #12025-04-13 15:23:14GET/en/instrument/biontech/3580
              #22025-04-13 15:23:15GET/csrf/ (ajax)
              #32025-04-13 15:23:15GET/params/ (ajax)